IDO2 and neoplasm: Besides, the indoleamine 2,3-dioxygenase (IDO1), a rate-limiting enzyme, is also discussed as a potential key target on tumor immune evasion and generates immunosuppressive metabolites through oxidizing tryptophan into kynurenine (13).